Search research articles
Contact Us
Filters
Showing results (251-260 of 298) with videos related to
Page
of 30
Sort By:
British Journal of Cancer
|
May 1, 1991
A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer
D I Jodrell, I E Smith, J L Mansi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 17, 2012
Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell
N A Rosenfelder, L Corsini, H McNair, et al.
British Journal of Cancer
|
July 17, 1998
A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer
T F Hickish, I E Smith, M C Nicolson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin
I E Smith, M E O'Brien, D C Talbot, et al.
Surgical Endoscopy
|
September 5, 2009
Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer
Christopher P Twine, S Ashley Roberts, Wyn G Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
M Brada, L Viviers, C Abson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2005
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
M Brada, S Ashley, A Dowe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2000
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy
L Assersohn, T J Powles, S Ashley, et al.
British Journal of Cancer
|
April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
S Postel-Vinay, H-T Arkenau, D Olmos, et al.
British Journal of Cancer
|
April 16, 2002
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort
C Foster, D G R Evans, R Eeles, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 298) with videos related to
Sort By:
Page
of 30
British Journal of Cancer
|
May 1, 1991
A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer
D I Jodrell, I E Smith, J L Mansi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 17, 2012
Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell
N A Rosenfelder, L Corsini, H McNair, et al.
British Journal of Cancer
|
July 17, 1998
A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer
T F Hickish, I E Smith, M C Nicolson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin
I E Smith, M E O'Brien, D C Talbot, et al.
Surgical Endoscopy
|
September 5, 2009
Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer
Christopher P Twine, S Ashley Roberts, Wyn G Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
M Brada, L Viviers, C Abson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2005
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
M Brada, S Ashley, A Dowe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2000
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy
L Assersohn, T J Powles, S Ashley, et al.
British Journal of Cancer
|
April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
S Postel-Vinay, H-T Arkenau, D Olmos, et al.
British Journal of Cancer
|
April 16, 2002
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort
C Foster, D G R Evans, R Eeles, et al.
Page
of 30